Logs: Bang Zheng
The following is a list of all job requests run via OpenSAFELY by Bang Zheng.
| Status | Organisation | Project | Workspace | Request ID | Backend | Jobs | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14211 | TPP | 2/2 | 2 years, 11 months ago 04 January 2023 10:39:48 UTC | View, Job request 14211 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14210 | TPP | 2/2 | 2 years, 11 months ago 04 January 2023 10:09:15 UTC | View, Job request 14210 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14208 | TPP | 2/2 | 2 years, 11 months ago 03 January 2023 23:01:59 UTC | View, Job request 14208 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14207 | TPP | 0/2 | 2 years, 11 months ago 03 January 2023 22:56:52 UTC | View, Job request 14207 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14206 | TPP | 2/2 | 2 years, 11 months ago 03 January 2023 22:49:17 UTC | View, Job request 14206 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14204 | TPP | 2/2 | 2 years, 11 months ago 03 January 2023 22:16:19 UTC | View, Job request 14204 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14203 | TPP | 1/1 | 2 years, 11 months ago 03 January 2023 18:54:47 UTC | View, Job request 14203 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14202 | TPP | 2/2 | 2 years, 11 months ago 03 January 2023 18:08:32 UTC | View, Job request 14202 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14201 | TPP | 2/2 | 2 years, 11 months ago 03 January 2023 16:29:17 UTC | View, Job request 14201 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14195 | TPP | 2/2 | 2 years, 11 months ago 03 January 2023 13:28:19 UTC | View, Job request 14195 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14194 | TPP | 1/1 | 2 years, 11 months ago 03 January 2023 13:14:34 UTC | View, Job request 14194 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14192 | TPP | 1/2 | 2 years, 11 months ago 03 January 2023 10:58:43 UTC | View, Job request 14192 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14188 | TPP | 1/2 | 2 years, 11 months ago 02 January 2023 22:01:03 UTC | View, Job request 14188 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14177 | TPP | 2/2 | 2 years, 11 months ago 28 December 2022 11:34:19 UTC | View, Job request 14177 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14176 | TPP | 1/2 | 2 years, 11 months ago 27 December 2022 22:55:14 UTC | View, Job request 14176 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14175 | TPP | 1/2 | 2 years, 11 months ago 27 December 2022 21:59:09 UTC | View, Job request 14175 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14174 | TPP | 2/2 | 2 years, 11 months ago 27 December 2022 21:20:26 UTC | View, Job request 14174 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14173 | TPP | 1/1 | 2 years, 11 months ago 27 December 2022 21:04:25 UTC | View, Job request 14173 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14159 | TPP | 1/1 | 2 years, 11 months ago 22 December 2022 16:08:38 UTC | View, Job request 14159 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14137 | TPP | 1/2 | 2 years, 11 months ago 21 December 2022 12:01:52 UTC | View, Job request 14137 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14135 | TPP | 2/2 | 2 years, 11 months ago 21 December 2022 11:14:26 UTC | View, Job request 14135 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14131 | TPP | 2/2 | 2 years, 11 months ago 20 December 2022 19:14:20 UTC | View, Job request 14131 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14130 | TPP | 2/2 | 2 years, 11 months ago 20 December 2022 19:04:43 UTC | View, Job request 14130 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14129 | TPP | 2/2 | 2 years, 11 months ago 20 December 2022 18:40:28 UTC | View, Job request 14129 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 13889 | TPP | 1/1 | 3 years ago 12 December 2022 21:10:05 UTC | View, Job request 13889 |